WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Inc Stock Ownership - Who owns Tango Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tango Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniella BeckmanChief Financial Officer2026-02-0310,204$12.26
$125.07kSell
Daniella BeckmanChief Financial Officer2026-02-03113$12.90
$1.46kSell
Adam CrystalPresident RD2026-02-0318,251$12.26
$223.70kSell
Adam CrystalPresident RD2026-02-03201$12.90
$2.59kSell
Barbara WeberDirector Executive Chair2026-02-0330,186$12.26
$369.99kSell
Barbara WeberDirector Executive Chair2026-02-03333$12.90
$4.29kSell
Third Rock Ventures IV LP10% Owner2025-10-23477,401$10.15
$4.85MSell
Third Rock Ventures IV LP10% Owner2025-09-25500,000$8.02
$4.01MSell
Third Rock Ventures IV LP10% Owner2025-09-16363,541$7.04
$2.56MSell
Third Rock Ventures IV LP10% Owner2025-09-0886,459$7.04
$608.67kSell

1 of 2

TNGX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNGX insiders and whales buy or sell their stock.

TNGX Shareholders

What type of owners hold Tango Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC17.80%23,961,472$302.15MInsider
Boxer Capital LLC11.28%15,187,092$191.51MInsider
Trv GP IV LLC10.30%13,863,975$174.82MInstitution
Boxer Capital Management LLC10.16%13,679,092$172.49MInsider
Third Rock Ventures IV LP9.95%13,386,574$168.80MInsider
Farallon Capital Management LLC7.99%10,757,000$135.65MInstitution
Ecor1 Capital LLC7.90%10,630,736$134.05MInstitution
Boxer Capital Management LLC7.26%9,771,485$123.22MInstitution
Tcg Crossover Management LLC6.34%8,536,196$107.64MInstitution
Aaron I. Davis5.20%6,993,450$88.19MInsider

1 of 3

TNGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNGX62.71%37.29%Net SellingNet Selling
MBX44.21%55.79%Net Buying
ARDX41.61%58.39%Net BuyingNet Selling
VCEL91.18%8.82%Net SellingNet Selling
PHVS89.05%0.00%
View Top Biotech Stocks

Tango Therapeutics Stock Ownership FAQ

Who owns Tango Therapeutics?

Tango Therapeutics (NASDAQ: TNGX) is owned by 104.00% institutional shareholders, 61.84% Tango Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Tango Therapeutics shareholder, owning 23.96M shares representing 17.80% of the company. Ecor1 Capital LLC's Tango Therapeutics shares are currently valued at $303.59M.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.